Howard Fine
Director, Weill Cornell Brain Tumor Center · New York Presbyterian Hospital
Credentials: · · · ·
History
PresentNeuro-Oncology Division · Cornell Univ Joan and Sanford I Weill Med Coll
- 1987–1989
Medical Oncology
- 1984–1987
Internal Medicine
Research
Cancer Cell · 2006 · Last of 12 authors · 1,939 citations
Journal of Clinical Oncology · 2009 · Last of 13 authors · 1,277 citations
Systematic review or meta-analysis · Cancer · 1993 · First of 5 authors · 710 citations
- PW
36 papers · 2 as a fellow
- PB
30 papers
- JL
24 papers
- WS
24 papers
21 papers
19 papers · 1 as a fellow
17 papers
- TK
16 papers
Grants
- 2026–2030
New York-New Jersey Center for Actionable NeuroHIV Biomarkers and Integrated Omics (NYJ-CAN-BIO)
National Institute of Mental Health · P30
Project lead · $193.1K · Weill Medical Coll of Cornell Univ
- 2024–2029
Identifying and Targeting 3D Regulatory Nodes That Maintain Glioblastoma Programs
National Institute of Neurological Disorders and Stroke · R01
PI · $2M · Weill Medical Coll of Cornell Univ
- 2017–2022
Human Brain Cancer, Rather Than Brain Cancer Cells, on a Plate
National Cancer Institute · DP1
Contact PI · $5.9M · Weill Medical Coll of Cornell Univ
- 1994–2002
Therapeutics Studies of Primary CNS Malignancies
National Cancer Institute · U01
Contact PI · $715.6K · Dana-Farber Cancer Inst
Clinical trials
- 2022–2026
Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma
Principal investigator · Suspended · Phase 2
Weill Medical College of Cornell University
- 2016–2026
A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
Principal investigator · Active not recruiting · Phase 2
Weill Medical College of Cornell University
- 2008–2011
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2007–2008
Pazopanib in Treating Patients With Recurrent Glioblastoma
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)